The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
End-of-study analysis from the phase III, randomized, double-blind, placebo (Pla)-controlled CLEOPATRA study of first-line (1L) pertuzumab (P), trastuzumab (H), and docetaxel (D) in patients (pts) with HER2-positive metastatic breast cancer (MBC).
 
Sandra M. Swain
Honoraria - Novartis
Consulting or Advisory Role - Cardinal Health; Daiichi Sankyo; Genentech/Roche; Genentech/Roche; Genomic Health; Inivata; Lilly; Pieris Pharmaceuticals; Tocagen
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Daiichi Sankyo; Genentech/Roche; Inivata; Lilly; NanoString Technologies
Other Relationship - AstraZeneca; Roche
 
David Miles
Honoraria - Roche/Genentech
Consulting or Advisory Role - Eisai; Roche/Genentech; Seagen
Travel, Accommodations, Expenses - Roche/Genentech
 
Sung-Bae Kim
Consulting or Advisory Role - Enzychem Lifesciences (Inst); Lilly (Inst); Novartis (Inst); Odonate Therapeutics (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
 
Young-Hyuck Im
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Eisai; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Roche/Genentech
Other Relationship - Roche
 
Vladimir Semiglazov
No Relationships to Disclose
 
Eva Ciruelos
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
Other Relationship - Roche
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Estefania Monturus
Employment - Roche
Stock and Other Ownership Interests - Roche (I)
Other Relationship - Roche
 
Emma Clark
Employment - Roche
Patents, Royalties, Other Intellectual Property - Roche
Other Relationship - Roche
 
Adam Knott
Employment - Roche
Stock and Other Ownership Interests - Roche
Other Relationship - Roche
 
Eleonora Restuccia
Employment - Roche
Stock and Other Ownership Interests - Roche
Other Relationship - Roche
 
Mark Benyunes
Employment - Genentech; Roche
Stock and Other Ownership Interests - Genentech; Roche
Patents, Royalties, Other Intellectual Property - Genentech; Roche
Travel, Accommodations, Expenses - Genentech; Roche
Other Relationship - Genentech; Roche
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Daiichi Sankyo; ERYTECH Pharma; Merus; Polyphor; Roche; Seagen
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Pique (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer; Roche